Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Hayward

Showing results (121-130 of 169) with videos related to

Pageof 17
Sort By:
The Lancet. Healthy Longevity|December 22, 2021
Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study): prospective cohort study in EnglandMaria Krutikov, Tom Palmer, Gokhan Tut, et al.
Health & Social Care in the Community|October 7, 2022
The economic case for hospital discharge services for people experiencing homelessness in England: An in-depth analysis with different service configurations providing specialist careMichela Tinelli, Raphael Wittenberg, Michelle Cornes, et al.
Occupational and Environmental Medicine|April 22, 2022
Occupation, work-related contact and SARS-CoV-2 anti-nucleocapsid serological status: findings from the Virus Watch prospective cohort studySarah Beale, Parth Patel, Alison Rodger, et al.
The Lancet. Infectious Diseases|June 26, 2021
Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort studyMadhumita Shrotri, Maria Krutikov, Tom Palmer, et al.
Wellcome Open Research|October 4, 2024
VIVALDI Cohort Profile: Using linked, routinely collected data and longitudinal blood sampling to characterise COVID-19 infections, vaccinations, and related outcomes in care home staff and residents in EnglandMaria Krutikov, David Bone, Oliver Stirrup, et al.
Wellcome Open Research|January 13, 2022
Household serial interval of COVID-19 and the effect of Variant B.1.1.7: analyses from prospective community cohort study (Virus Watch)Cyril Geismar, Ellen Fragaszy, Vincent Nguyen, et al.
Open Forum Infectious Diseases|January 30, 2023
Clinical Effectiveness of SARS-CoV-2 Booster Vaccine Against Omicron Infection in Residents and Staff of Long-term Care Facilities: A Prospective Cohort Study (VIVALDI)Oliver Stirrup, Madhumita Shrotri, Natalie L Adams, et al.
NIHR Open Research|September 17, 2024
The changing contributory role to infections of work, public transport, shopping, hospitality and leisure activities throughout the SARS-CoV-2 pandemic in England and WalesSusan Hoskins, Sarah Beale, Vincent G Nguyen, et al.
NIHR Open Research|August 15, 2024
Protocol for VIVALDI social care: Pilot study to reduce infections, outbreaks and antimicrobial resistance in care homes for older adultsMaria Krutikov, Zoe Fry, Borscha Azmi, et al.
The Journal of Infectious Diseases|December 2, 2011
Use of a human influenza challenge model to assess person-to-person transmission: proof-of-concept studyBen Killingley, Joanne E Enstone, Jane Greatorex, et al.
Pageof 17

Showing results (121-130 of 169) with videos related to

Sort By:
Pageof 17
The Lancet. Healthy Longevity|December 22, 2021
Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study): prospective cohort study in EnglandMaria Krutikov, Tom Palmer, Gokhan Tut, et al.
Health & Social Care in the Community|October 7, 2022
The economic case for hospital discharge services for people experiencing homelessness in England: An in-depth analysis with different service configurations providing specialist careMichela Tinelli, Raphael Wittenberg, Michelle Cornes, et al.
Occupational and Environmental Medicine|April 22, 2022
Occupation, work-related contact and SARS-CoV-2 anti-nucleocapsid serological status: findings from the Virus Watch prospective cohort studySarah Beale, Parth Patel, Alison Rodger, et al.
The Lancet. Infectious Diseases|June 26, 2021
Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort studyMadhumita Shrotri, Maria Krutikov, Tom Palmer, et al.
Wellcome Open Research|October 4, 2024
VIVALDI Cohort Profile: Using linked, routinely collected data and longitudinal blood sampling to characterise COVID-19 infections, vaccinations, and related outcomes in care home staff and residents in EnglandMaria Krutikov, David Bone, Oliver Stirrup, et al.
Wellcome Open Research|January 13, 2022
Household serial interval of COVID-19 and the effect of Variant B.1.1.7: analyses from prospective community cohort study (Virus Watch)Cyril Geismar, Ellen Fragaszy, Vincent Nguyen, et al.
Open Forum Infectious Diseases|January 30, 2023
Clinical Effectiveness of SARS-CoV-2 Booster Vaccine Against Omicron Infection in Residents and Staff of Long-term Care Facilities: A Prospective Cohort Study (VIVALDI)Oliver Stirrup, Madhumita Shrotri, Natalie L Adams, et al.
NIHR Open Research|September 17, 2024
The changing contributory role to infections of work, public transport, shopping, hospitality and leisure activities throughout the SARS-CoV-2 pandemic in England and WalesSusan Hoskins, Sarah Beale, Vincent G Nguyen, et al.
NIHR Open Research|August 15, 2024
Protocol for VIVALDI social care: Pilot study to reduce infections, outbreaks and antimicrobial resistance in care homes for older adultsMaria Krutikov, Zoe Fry, Borscha Azmi, et al.
The Journal of Infectious Diseases|December 2, 2011
Use of a human influenza challenge model to assess person-to-person transmission: proof-of-concept studyBen Killingley, Joanne E Enstone, Jane Greatorex, et al.
Pageof 17